management of side effects with tas-102
Published 6 years ago • 383 plays • Length 2:49Download video MP4
Download video MP3
Similar videos
-
5:42
role of tas-102 (trifluridine/tipiracil) in advanced colorectal cancer
-
1:28
dr. overman on distinctions between regorafenib and tas-102 in crc
-
7:54
regorafenib vs tas-102 salvage therapy
-
5:23
optimal management of side effects for patients with colorectal cancer
-
2:54
safety of tas-102 in patients with metastatic gastric/ge junction and colorectal cancer
-
3:32
lonsurf-day one
-
35:56
anti - tb drugs side effects and hepatotoxicity (management pearls)
-
35:57
on target: using trop-2-directed therapeutics for urothelial carcinoma
-
5:59
dosing and side effect management in metastatic crc
-
4:28
proactive side effect management with regorafenib
-
1:12
dr. lenz on choosing between regorafenib and tas-102 in crc
-
3:51
side effect management in colorectal cancer
-
4:19
the role of tas-102 in metastatic colorectal cancer
-
2:30
side effects of later-line options in colorectal cancer
-
3:53
when you have decided to prescribe trifluridine/tipiracil
-
1:16
dr. eng on roles of regorafenib and tas-102 in crc treatment
-
0:55
dr. yoshino discusses the safety profile of tas-102
-
7:43
practical advice for using trifluridine/tipiracil
-
1:38
dr. udit verma on managing regorafenib side effects in crc
-
6:43
tas-102 in metastatic colorectal cancer
-
4:54
the first oral fluoropyrimidine for mcrc—tas-102
-
11:24
managing toxicities associated with regorafenib